Business
AstraZeneca COVID-19 vaccine: Huge setback for Australia’s hopes – Herald Sun
The coronavirus vaccine Australia has invested in has been dealt a major setback after researchers uncovered a suspected serious adverse reaction in a trial participant.
The coronavirus vaccine Australia has invested in has been dealt a major setback after researchers uncovered a suspected serious adverse reaction in a trial participant.
The vaccine, being developed by pharmaceutical giant AstraZeneca and the University of Oxford, is being tested at dozens of sites around the world.
The stage 3 trial – the final stage before safety and efficacy data can be submitted to regulators for approval – has tens of thousands of participants.
But the adverse reaction, …
-
Noosa News21 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News23 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General23 hours agoNo ‘band-aid solution’: sweating coal risky business
-
General23 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash